Skip to content

OS Therapies OSTX Accounts Payable - Other Current

Accounts Payable - Other Current at other companies

OS Therapies logo
OS TherapiesOSTX
$70
TPG Inc. logo
TPG Inc.TPG
$738.62M+13.7%
StepStone Group Inc. logo
StepStone Group Inc.STEP
$362.83M+9.3%
TRN
Terreno RealtyTRNO
$96.38M+44.5%
BGC Group, Inc. logo
BGC Group, Inc.BGC
$32.33M-39.8%
International Paper logo
International PaperIP
$180M+50.0%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableOtherCurrentAndNoncurrent.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's accounts payable - other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's accounts payable - other current?
OS Therapies (OSTX) reported accounts payable - other current of $70 in Q1 2026.
What is the long-term trend for OS Therapies's accounts payable - other current?
Over 2 years (2023 to 2025), OS Therapies's accounts payable - other current has grown at a -100.0% compound annual growth rate (CAGR), from $32.1K to $0.
What does accounts payable - other current mean?
This represents outstanding payment obligations to vendors and service providers that do not fall under standard trade payables categories. It captures miscellaneous short-term liabilities necessary for ongoing operational activities. Tracking this provides insight into the company's management of working capital and short-term credit terms with non-core suppliers.